Indiwell Pharmaceuticals Private Limited
About Indiwell Pharmaceuticals Private Limited
Data last updated:
Indiwell Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 01 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2017PTC295665. Its GSTIN is 27AAECI5205L1ZI (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Yashvant Gopinath Khaire and Shankar Tukaram Sonawane.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at B – 13/3 – 4 Bimashankar Chs Near Ryan Internation School Sector 19A, Navi Mumbai, Maharashtra, India – 400706.
As per the financials filed for FY 2022, the company reported a revenue of ₹8.26 Lakh, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹34,148 (net margin 4.1%) and EBITDA of ₹46,146 (EBITDA margin 5.6%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Indiwell Pharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressB – 13/3 – 4 Bimashankar Chs Near Ryan Internation School Sector 19A, Navi Mumbai, Maharashtra, India – 400706
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Indiwell Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Indiwell Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Indiwell Pharmaceuticals Private Limited, buy the company report.
Financials of Indiwell Pharmaceuticals Private Limited
FY 2022 filings availableIndiwell Pharmaceuticals Private Limited reported revenue of ₹8.26 Lakh (up 26% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 26% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 14%. EBITDA rose 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹46,146 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34,148 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 4.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Indiwell Pharmaceuticals Private Limited, buy the company report.
Board of directors of Indiwell Pharmaceuticals Private Limited
Indiwell Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yashvant Gopinath Khaire | Director | 01 Jun 2017 | 9 Years 4 Months | Current |
| Shankar Tukaram Sonawane | Director | 01 Jun 2017 | 9 Years 4 Months | Current |
| Yogesh Balu Sonawane | Director | 01 Jun 2017 | 9 Years 4 Months | Current |
Peer comparison
Indiwell Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dicore Pharmaceuticals Private Limited | ₹8.34 Lakh (FY 2024) | -21.0% | New Delhi, Delhi, India | |||
| Foxcem Pharmaceuticals Limited | ₹8.32 Lakh (FY 2021) | -33.0% | Solan, Himachal Pradesh, India | |||
| Indiwell Pharmaceuticals Private Limitedthis company | ₹8.26 Lakh (FY 2022) | ₹34,148 | 4.1% | 26.0% | Navi Mumbai, Maharashtra, India | |
| Samuels Pharmaceuticals Private Limited | ₹8.21 Lakh (FY 2025) | 63.0% | Haryana, India | |||
| Medikamente Pharmaceuticals Private Limited | ₹8.19 Lakh (FY 2025) | 17.0% | Ghaziabad, Uttar Pradesh, India |
To see the full peer comparison of Indiwell Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Indiwell Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indiwell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Indiwell Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECI5205L1ZI | Maharashtra | Active | 30 Aug 2017 |
To see the full GST registrations and return filing status of Indiwell Pharmaceuticals Private Limited, buy the company report.
Recent activity
Indiwell Pharmaceuticals Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Shankar Tukaram Sonawane was appointed as Director on 01 Jun 2017.
Frequently asked questions
Indiwell Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 01 June 2017 (9+ years old) and is registered under CIN U51909MH2017PTC295665.
Indiwell Pharmaceuticals has 3 current directors:
- Yashvant Gopinath Khaire - Director
- Shankar Tukaram Sonawane - Director
- Yogesh Balu Sonawane - Director
The latest financial statements of Indiwell Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Indiwell Pharmaceuticals is 27AAECI5205L1ZI, registered in Maharashtra.
The CIN (Corporate Identification Number) of Indiwell Pharmaceuticals is U51909MH2017PTC295665. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indiwell Pharmaceuticals was incorporated on 01 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Indiwell Pharmaceuticals by revenue are Dicore Pharmaceuticals Private Limited, Foxcem Pharmaceuticals Limited, Samuels Pharmaceuticals Private Limited, Medikamente Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Shankar Tukaram Sonawane was appointed as Director on 01 Jun 2017. Yashvant Gopinath Khaire was appointed as Director on 01 Jun 2017. Yogesh Balu Sonawane was appointed as Director on 01 Jun 2017.
The registered office of Indiwell Pharmaceuticals is at B – 133 – 4 Bimashankar Chs Near Ryan Internation School Sector 19A, Navi Mumbai, Maharashtra, India – 400706.
Indiwell Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Indiwell Pharmaceuticals is compliant as of 08 September 2026. The company is actively filing with the Registrar of Companies.